Full spectrum profile to include major and minor Cannabinoids as well as Terpenes Unique trichome structure provides for potentially higher solubility and bio-availability With Trichomes representing...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – April 7, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTC:CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") announced today a financing...
VINIA® sales orders grew 112% compared to Q1 2021 to reach USD 787k Reiterating guidance for year-on-year sales orders growth of 2.5-3.5X to reach USD 5M...
Now producing Cannabis biomass in large scale industrial bioreactors under the current R&D license. Commencing the process of transitioning the current Israeli Cannabis R&D license to...
Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – March 11, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or “the Company”) invites its shareholders and the...
New name to reflect the Biotech power of combining plant cell growth with elicitation of specific molecules to produce unique compounds of high human utility value...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – February 10, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) a fast-growing Biotech firm...
Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – February 3, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or “the Company”) is pleased to announce that...
2022 Revenue will include sales of VINIA® and Cannabis, both with high gross margins Major investments in the BioFarming platform and Intellectual property New patent application...
The Company is now producing Cannabis in industrial scale bioreactors and has entered the final stage of its Cannabis commercialization program Vancouver, British Columbia, and Rehovot,...